Company Profile
Pacific Edge Limited, a cancer diagnostics company provides development and commercialization of bladder cancer diagnostic and prognostic tests for patients. Its business is organized into two segments, Commercial and Research.
The company offers Cxbladder, a genomic urine biomarker test for the stratification and surveillance of bladder cancer. It also develops Cxbladder Triage, a frontline diagnostic product that helps de-intensify clinical work-up in microhematuria patients.
Its portfolio also includes Cxbladder Detect, which improve practice workflow and efficiency in urological care, Cxbladder Triage Plus, a non-invasive surveillance alternative that can reduce the burden of repeated cystoscopy in patients, and Cxbladder Monitor, a non-invasive surveillance alternative that reduces the burden of repeated cystoscopy in patients with a recurrent non-muscle invasive bladder cancer.
Additionally, it is developing products for bladder, gastric, colorectal and endometrial cancers, and melanoma. Incorporated in 2001, Pacific Edge is headquartered in Dunedin, New Zealand.